S283 SARS-COV-2 (COVID-19) IGG ANTIBODY
Specimen: 3 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
| Stability: |
|
Method: CLIA
Comment: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of Coronavirus disease 2019 (COVID-19). It is an infectious disease first identified in 2019 in Wuhan, the capital of China’s Hubei province. It has spread globally, resulting in the 2019–2020 Coronavirus pandemic. Common symptoms include fever, cough, shortness of breath, muscle pain, sputum production, diarrhoea, sore throat, abdominal pain, and loss of smell or taste. Majority of cases result in mild symptoms while in a few cases it may progress to pneumonia and multi-organ failure. The virus is mainly spread during close contact via respiratory droplets produced when people cough or sneeze.
Report: Sample Daily by 11 am; Report Same day
Usage: This assay must not be used for diagnosis of COVID-19.. This assay is intended to be used for qualitative detection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) IgG antibodies as per ICMR in the below mentioned groups only: Immunocompromised patients; Individuals in containment zones; Health care workers; Security personnel; Police and paramilitary personnel civil defense & volunteers; Press corps; Rural, tribal population (after reverse migration); Industrial workers or labour force; Farmers, vendors visiting large markets; Staff in municipal bodies; Drivers; Bank, post, couriers, telecom offices; Shops; Air travel related staff; International operations; Congregate settings and Prisons.
Doctor Specialty: Physician
Disease: Infections
Components:
Courier Charges:
Home Collection: Available
Department:
Pre Test Information:
